Abstract
Many individuals treated for depression suffer relapse or recurrence after treatment. Known risk factors include number of previous depressive episodes and residual symptoms after treatment. Both relapse/recurrence rates and predictors of relapse/recurrence, however, may differ between various settings. To perform a naturalistic evaluation of the sustained effectiveness of treatment for adult clinical depression in a psychiatric out-patient setting and to examine psychosocial and clinical predictors of relapse/recurrence. 51 individuals, who were successfully treated/discharged from psychiatric care 12 months prior, were assessed regarding current depressive status and regarding relapse and recurrence. Logistic regression was used to assess the predictive impact of the variables measured. At the 12-month follow-up, 26 % of the participants were in complete remission, 45 % were in partial remission, and 29 % were clinically depressed. In 1 year, 61 % suffered a new depressive episode. Having a greater number of previous episodes and having no partner significantly increased the risk of relapse or recurrence. A high prevalence of depression and partially remitted depression is reported at 12-month follow up, and a large proportion of the sample would likely benefit from active treatment. Relapse/recurrence rates are higher in this study than in many other studies, and it may be hypothesized that they are generally higher in psychiatric settings than in primary care. If so, this would indicate the need for a different treatment strategy in the psychiatric care of depression, with emphasis on long-term management of depression.
Similar content being viewed by others
References
Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, et al.: Global variation in the prevalence and incidence of major depressive disorder: A systematic review of the epidemiological literature. Psychological Medicine 43:471–481, 2013.
Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER: The economic burden of depression in 1990. Journal of Clinical Psychiatry 54:405–418, 1993.
Eaton WW, Shao H, Nestadt G, Lee HB, Lee BH, Bienvenu OJ, et al.: Population-based study of first onset and chronicity in major depressive disorder. Archives of General Psychiatry 65:513–520, 2008.
Shapiro DA, Rees A, Barkham M, Hardy G, Reynolds S, Startup M: Effects of treatment duration and severity of depression on the maintenance of gains after cognitive-behavioral and psychodynamic-interpersonal psychotherapy. Journal of Consulting Psychology 63:378–387, 1995.
Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O’Reardon JP, et al.: Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of General Psychiatry 62:417–422, 2005.
Williams N, Simpson AN, Simpson K, Nahas Z: Relapse rates with long-term antidepressant drug therapy: A meta-analysis. Human Psychopharmacology 24:401–408, 2009.
Vittengl JR, Clark LA, Dunn TW, Jarrett RB: Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive-behavioral therapy’s effects. Journal of Consulting Psychology 75:475–488, 2007.
Burcusa SL, Iacono WG: Risk for recurrence in depression. Clinical Psychology Review 27:959–985, 2007.
Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman ATF: Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatrica Scandinavica 122:184–191, 2010.
Akerblad A-C, Bengtsson F, von Knorring L, Ekselius L: Response, remission and relapse in relation to adherence in primary care treatment of depression: A 2-year outcome study. International Clinical Psychopharmacology 21:117–124, 2006.
Poutanen O, Mattila A, Seppälä NH, Groth L, Koivisto A-M, Salokangas RKR. Seven-year outcome of depression in primary and psychiatric outpatient care: Results of the TADEP (Tampere Depression) II Study. Nordic Journal of Psychiatry 61:62–70, 2007.
Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A: Residual symptoms after partial remission: an important outcome in depression. Psychological Medicine 25:1171–1180, 1995.
Svanborg P, Åsberg M: A new self-rating scale for depression and anxiety states based on the comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica 89:21–28, 1994.
First MB, Gibbon M: User’s Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I: Clinician Version. Arlington, American Psychiatric Publishing, 1997.
Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al.: Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry 48:851–855, 1991.
Zimmerman M, Posternak MA, Chelminski I: Defining remission on the Montgomery-Asberg depression rating scale. Journal of Clinical Psychiatry 65:163–168, 2004.
Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR: A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology 49:1373–1379, 1996.
Viinamäki H, Hintikka J, Tolmunen T, Honkalampi K, Haatainen K, Koivumaa-Honkanen H: Partial remission indicates poor functioning and a high level of psychiatric symptoms: A 3-phase 6-year follow-up study on major depression. Nordic Journal of Psychiatry 62:437–443, 2008.
Williams N, Simpson AN, Simpson K, Nahas Z: Relapse rates with long-term antidepressant drug therapy: A meta-analysis. Human Psychopharmacology 24:401–408, 2009.
Jarrett RB, Kraft D, Schaffer M, Witt-Browder A, Risser R, Atkins DH, et al.: Reducing relapse in depressed outpatients with atypical features: A pilot study. Psychotherapy and Psychosomatics 69:232–239, 2000.
Gagne S, Vasiliadis H-M, Preville M: Gender differences in general and specialty outpatient mental health service use for depression. BMC Psychiatry 14:135, 2014.
Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al.: Use of mental health services in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica 109:47–54, 2004.
Mammen G, Faulkner G: Physical activity and the prevention of depression: A systematic review of prospective studies. The American Journal of Preventive Medicine 45:649–657, 2013.
Holländare F, Johnsson S, Randestad M, Tillfors M, Carlbring P, Andersson G, et al.: Randomized trial of internet-based relapse prevention for partially remitted depression. Acta Psychiatrica Scandinavica 124:285–294, 2011.
Berlanga C, Heinze G, Torres M, Apiquián R, Caballero A: Personality and clinical predictors of recurrence of depression. Psychiatric services (Washington, DC) 50:376–380, 1999.
O’Leary DA, Lee AS: Seven year prognosis in depression. Mortality and readmission risk in the Nottingham ECT cohort. The British Journal of Psychiatry 169:423–429, 1996.
Kessing LV, Andersen PK, Mortensen PB: Predictors of recurrence in affective disorder: A case register study. Journal of Affective Disorders 49:101–108, 1998.
Gonzales LR, Lewinsohn PM, Clarke GN: Longitudinal follow-up of unipolar depressives: an investigation of predictors of relapse. Journal of Consulting and Clinical Psychology 53:461–469, 1985.
Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, et al.: Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. The American Journal of Psychiatry 156:1000–1006, 1999.
Lewinsohn PM, Hoberman HM, Rosenbaum M: A prospective study of risk factors for unipolar depression. The Journal of Abnormal Psychology 97:251–264, 1988.
Wilhelm K, Parker G, Dewhurst-Savellis J, Asghari A: Psychological predictors of single and recurrent major depressive episodes. Journal of Affective Disorders 54:139–147, 1999.
Acknowledgments
The authors gratefully acknowledge the participants for their involvement in this project. The author also wishes to thank Dan Comstedt and Lisa Haraldsson for their contribution to this study.
Conflict of interest
Olof Johansson was, at the time of the study, employed by the psychiatric hospital in which the study was conducted. Lars-Gunnar Lundh and Jonas Bjärehed declare that they have no conflict of interest.
Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johansson, O., Lundh, LG. & Bjärehed, J. 12-Month Outcome and Predictors of Recurrence in Psychiatric Treatment of Depression: A Retrospective Study. Psychiatr Q 86, 407–417 (2015). https://doi.org/10.1007/s11126-015-9341-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11126-015-9341-y